Investments (Tables)

9 Months Ended

Mar. 31, 2026

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-Sale Securities Reconciliation

The Company’s investments of marketable securities as of June 30, 2025, consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value

U.S. treasury securities	$	176,338	$	388	$	(65)	$	176,661
Agency securities	3,197		19		—		3,216
Certificates of deposit and time deposits	10,000		—		—		10,000
Commercial paper	19,697		—		—		19,697
Corporate debt securities	214,190		527		(23)		214,694



Total marketable securities	$	423,422	$	934	$	(88)	$	424,268

Schedule of Investments Classified by Contractual Maturity Date

The table below summarizes the Company’s marketable securities by remaining contractual maturity as of June 30, 2025 (in thousands):


	Marketable Securities
Due in one year or less	$	271,923
Due in one year through five years	152,345
Total marketable securities	$	424,268

Schedule of Strategic Investments

The Company’s investments of privately held debt securities as of March 31, 2026, consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Privately held debt securities	$	7,180	$	—	$	(2,750)	$	4,430

The Company’s investments of privately held debt securities as of June 30, 2025, consisted of the following (in thousands):


	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Privately held debt securities	$	7,780	$	—	$	(3,350)	$	4,430

The carrying values for privately held equity securities as of March 31, 2026 are summarized below (in thousands):


	Privately held equity securities
Initial total cost	$	143,802
Cumulative net gains	7,284
Carrying value	$	151,086

The carrying values for privately held equity securities as of June 30, 2025 are summarized below (in thousands):


	Privately held equity securities
Initial total cost	$	166,302
Cumulative net losses	(1,909)
Carrying value	$	164,393

Schedule of Unrealized Gain (Loss) on Investments

The components of gains and losses on strategic investments were as follows (in thousands):


	Three Months Ended March 31,				Nine Months Ended March 31,
	2026		2025		2026		2025
Unrealized gains recognized on publicly traded equity securities	$	—	$	—	$	24,729	$	—
Unrealized gains recognized on privately held equity securities	—		—		9,846		—
Unrealized losses recognized on privately held equity securities including impairment	(2,321)		(967)		$	(3,569)	$	(967)
Unrealized losses on privately held debt securities	—		—		(250)		—
Unrealized gains (losses), net	$	(2,321)	$	(967)	$	30,756	$	(967)
Realized losses recognized on sales of publicly traded equity securities	—		—		(10,071)		—
Realized losses recognized on privately held equity securities	—		(500)		—		(3,145)
Realized gains recognized on privately held equity securities	402		—		1,367		—
Realized gains on debt securities	$	228	$	—	$	228	$	—
Gains (losses) on strategic investments, net	$	(1,691)	$	(1,467)	$	22,280	$	(4,112)
Unrealized gains (losses) recognized during the reporting period on privately held equity securities still held at the reporting date	$	(2,321)	$	(967)	$	6,277	$	(967)

Schedule of Equity Method Investments

The following table sets forth the carrying amounts of the equity method investment and the movements during fiscal year 2025 and the nine months ended March 31, 2026 (in thousands):


	Equity Method Investment
Balance as of June 30, 2024	$	74,510
Share of losses	(20,433)
Effect of change in exchange rates	(958)
Balance as of June 30, 2025	53,119

Effect of change in exchange rates	2,273
Balance as of March 31, 2026	$	55,392

Atlassian Corp 10-Q